Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
“Endosomal pH buffering” refers to the complex and dynamic biological processes modulating and maintaining the acidic environment inside endosomes, crucial for endosomal maturation, cargo release, receptor recycling, and intracellular trafficking. The main contributors to acidification are proton-pumping vacuolar ATPases (V-ATPases), while Na+/H+ exchangers and anion channels regulate pH and ionic balance. Small molecule modulators (e.g., bafilomycin A1, chloroquine) are frequently used experimentally to alter endosomal pH, but these often lack specificity and may disrupt multiple cellular compartments. Although not a single molecular target, the components that regulate endosomal pH are under active investigation as potential modulators of infection, neurodegeneration, and drug delivery.
Inhibition of V-ATPase to block proton pumping; Buffering capacity to raise endosomal pH (e.g., via "proton sponge" effect or weak base accumulation)
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Endosomal pH buffering.